Outsmarting Cancer to Deliver More Cures

CARGO is engineering best-in-class CARs that overcome resistance and address barriers to access so that more patients benefit from potentially curative therapies.

Science

News

  • CARGO Therapeutics Raises $200 Million in Oversubscribed, Upsized Series A Financing to Advance its Pipeline of Next Generation CAR T-Cell Therapies

    Read More ⟶

CARGO Therapeutics Now Hiring. Join us to make a difference.
Open Positions ⟶